A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
OncoNano Medicine, Inc.
Columbia University
National Cancer Institute (NCI)
Celgene
sigma-tau i.f.r. S.p.A.
Santa Maria Biotherapeutics
BIND Therapeutics
Calando Pharmaceuticals
Tufts Medical Center
Case Comprehensive Cancer Center